Pliant Therapeutics (PLRX) Earnings Date, Estimates & Call Transcripts $1.66 -0.02 (-1.19%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$1.62 -0.04 (-2.65%) As of 08/8/2025 07:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Pliant Therapeutics Earnings Summary Pliant Therapeutics released Q2 2025 earnings on August 7, 2025, reporting an EPS of -$0.71, which missed analysts' consensus estimates of -$0.62 by $0.09. With a trailing EPS of -$3.61, Pliant Therapeutics' earnings are expected to decrease next year, from ($3.64) to ($3.72) per share. Q2 2025 Earnings ResourcesQ2 2025 Earnings Report Quarterly Report (10-Q)Powered by Latest Q2 Earnings DateAug. 7EstimatedConsensus EPS (Aug. 7) -$0.62 Actual EPS (Aug. 7) -$0.71 Missed By -$0.09 Get Pliant Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Pliant Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataPLRX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.PLRX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Pliant Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$1.00-$0.86-$0.93Q2 20252-$0.55-$0.50-$0.53Q3 20252-$0.51-$0.51-$0.51Q4 20252-$0.65-$0.47-$0.56 Pliant Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025-$0.62-$0.71 -$0.09-$0.71--3/3/2025Q4 2024-$0.99-$0.82+$0.17-$0.82$0.08M-11/7/2024--$0.99-$0.95+$0.04-$0.95--8/7/2024--$0.85-$0.92 -$0.07-$0.92--5/6/2024Q1 2024-$0.76-$0.78 -$0.02-$0.78--2/27/2024Q4 2023--$0.69--$0.69--11/9/2023Q3 2023-$0.78-$0.70+$0.08-$0.70--8/9/2023Q2 2023-$0.73-$0.70+$0.03-$0.70$1.10M$0.25M Pliant Therapeutics Earnings - Frequently Asked Questions When did Pliant Therapeutics announce their last quarterly earnings? Pliant Therapeutics (NASDAQ:PLRX) last announced its quarterly earning data on Thursday, August 7, 2025. Learn more on PLRX's earnings history. Did Pliant Therapeutics beat their earnings estimates last quarter? In the previous quarter, Pliant Therapeutics (NASDAQ:PLRX) missed the analysts' consensus estimate of ($0.62) by $0.09 with a reported earnings per share (EPS) of ($0.71). Learn more on analysts' earnings estimate vs. PLRX's actual earnings. How much revenue does Pliant Therapeutics generate each year? Pliant Therapeutics (NASDAQ:PLRX) has a recorded annual revenue of $1.58 million. How much profit does Pliant Therapeutics generate each year? Pliant Therapeutics (NASDAQ:PLRX) has a recorded net income of -$210.30 million. PLRX has generated -$3.61 earnings per share over the last four quarters. What is Pliant Therapeutics' EPS forecast for next year? Pliant Therapeutics' earnings are expected to decrease from ($3.64) per share to ($3.72) per share in the next year. More Earnings Resources from MarketBeat Related Companies Tectonic Therapeutic Earnings Date iTeos Therapeutics Earnings Date Vigil Neuroscience Earnings Date Aquestive Therapeutics Earnings Date Eton Pharmaceuticals Earnings Date Astria Therapeutics Earnings Date Fulcrum Therapeutics Earnings Date Prothena Earnings Date Olema Pharmaceuticals Earnings Date CryoPort Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Airbnb Beats Earnings, But the Growth Story Is Losing AltitudeDutch Bros Just Flipped the Script With a Massive Earnings BeatIs Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity?Constellation Energy’s Earnings Beat Signals a New EraRealty Income Rallies Post-Earnings Miss—Here’s What Drove ItDon't Mix the Signal for Noise in Super Micro Computer's EarningsWhy Monolithic Power's Earnings and Guidance Ignited a Rally This page (NASDAQ:PLRX) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pliant Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pliant Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PLRX Stock Alerts